Evidence map›Paper›PMID 11283052›Full record

ArticleJournal of clinical microbiology2001

Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma.

A M Caliendo, R Schuurman, B Yen-Lieberman, S A Spector, J Andersen, R Manjiry, C Crumpacker, N S Lurain, A Erice, CMV Working Group of the Complications of HIV Disease RAC, AIDS Clinical Trials Group

Open access · greenAbstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Cytomegalovirus infection and the gastrointestinal tract.Current gastroenterology reports · 2012
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Evaluation of molecular diagnostic assays for fungal infections.The Journal of molecular diagnostics : JMD · 2006
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

A M CaliendoDepartment of Pathology and Laboratory Medicine and Department of Medicine, Division of Infectious Diseases, Emory University, Atlanta, Georgia.
R Schuurman
B Yen-Lieberman
S A Spector
J Andersen
R Manjiry
C Crumpacker
N S Lurain
A Erice
CMV Working Group of the Complications of HIV Disease RAC, AIDS Clinical Trials Group
Harvard University · USUtrecht University · NLCleveland Clinic · USEmory University · USPresbyterian St. Luke's Medical Center · USUniversity of California, San Diego · USUniversity of Minnesota Medical Center · US

Funding

VIROLOGY QUALITY ASSESSMENT PROGRAM-N01AI085354 · NIAID · RUSH UNIVERSITY MEDICAL CENTER · 1998 to 2003
$1.4M
VIROLOGY QUALITY ASSESSMENT PROGRAMN01AI85354 · NIAID · PI BREMER, JAMES W · 2007 to 2007
$283k
NIAID NIH HHS N01 AI085354NIAID NIH HHS N01 AI85354
6 · The paper itself

Abstract

We analyzed the performance characteristics of the qualitative AMPLICOR CMV Test (Roche Molecular Systems, Pleasanton, Calif.) and quantitative COBAS AMPLICOR CMV MONITOR Test (Roche Molecular Systems) assays and compared the performance of the AMPLICOR quantitative assay with an in-house-developed cytomegalovirus (CMV) DNA PCR assay. The quantitative AMPLICOR assay was found to be more sensitive than the qualitative AMPLICOR assay. The quantitative AMPLICOR assay has a lower limit of sensitivity of 400 CMV DNA copies/ml of plasma and is linear to 50,000 CMV DNA copies/ml of plasma. Compared to the in-house PCR assay, the AMPLICOR quantitative assay gave lower viral load values at all concentrations tested, but the difference between the two assays was not consistent across the entire dynamic range of the AMPLICOR quantitative assay. At the lower end of the assay, the viral load values obtained with the in-house PCR assay were three- to fivefold (0.5 to 0.7 log units) higher than those measured with the AMPLICOR assay. At higher input concentrations, the differences between the two assays approached 10-fold. This direct comparison of the in-house assay and the quantitative AMPLICOR assay provides the ability to compare previously published in-house data with an assay widely available for future research and clinical monitoring of patients with CMV infections.

Indexed as

Viral LoadCytomegalovirusCytomegalovirus InfectionsDNA, ViralHumansPolymerase Chain ReactionReagent Kits, DiagnosticDNA, ViralReagent Kits, Diagnostic

Identifiers

PMID11283052
PMCPMC87935
OpenAlexW2064448893

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.